John R. Goffin
699 Concession St
Hamilton, ON, Canada
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Emphysema Versus COPD in Patients Receiving Immune Checkpoint Inhibitors for NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 23, 2025
Cell-free tumour DNA in bronchoalveolar lavage: a proof of concept study.
Journal: ERJ open research
Published: October 25, 2025
CAPOX vs. FOLFOX for Colorectal Cancer-Real World Outcomes in Ontario, Canada.
Journal: Current oncology (Toronto, Ont.)
Published: June 22, 2025
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial.
Journal: Journal for immunotherapy of cancer
Published: November 11, 2024
The Impact of Chronic Obstructive Pulmonary Disease on Immune Checkpoint Inhibitor Effectiveness in Non-small Cell Lung Cancer: A Population Health Study.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 09, 2024
Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 08, 2024
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: December 05, 2023
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Journal: Lancet (London, England)
Published: May 30, 2023
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.
Journal: Therapeutic advances in medical oncology
Published: February 21, 2023
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 21, 2022
Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
Journal: BMC pulmonary medicine
Published: August 13, 2020
Last Updated: 09/26/2026